Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Guy Gordon who wrote (1113)	8/1/1997 6:03:00 AM
From: biopicker	of 6136

Guy-- In my opinion, all the major drug companies, including Merck, are now momentum-players' darlings, and I do not believe they have attraction at these prices. I would stay away. The Agouron story has just begun, and this is the "top of the second" in a nine-inning balgame. I believe they wil leverage the very substantial revenues from Viracept into their enormously rich and exciting pipeline While predicting prices is a very difficult business, $300+ is not out of the question over the next three years. There is a small company, PCYC, which looks interesting since it has some very interesting drug candidates. It will take time but could be a big stock over the next few years. Cheers! Biopicker

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next